Model | Rank | SNP | CHR | Position | 1st stage | 2nd stage | Final stage | Combined | Genotype | Related gene | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
X 2 | P | X 2 | P | X 2 | P | Q | X 2 | P | Abnormal | Normal | ||||||
Trend | 1 | rs2677879 | 18 | 2537500 | 4.078 | 0.0435 | 6.071 | 0.0137 | 6.585 | 0.0103 | 0.0309* | 16.56 | 4.72E-05 | 13/51/84 | 28/73/51 | METTL4 |
Trend | 2 | rs3803800 | 17 | 7403693 | 7.797 | 0.0052 | 4.983 | 0.0256 | 0.2319 | 0.6301 | 0.6301 | 7.157 | 0.007467 | 20/73/56 | 6/75/73 | TNFSF13 |
Trend | 3 | rs3777722 | 6 | 167272094 | 7.531 | 0.0061 | 1.063 | 0.3025 | 1.063 | 0.3025 | 0.4538 | 4.367 | 0.03665 | 20/68/60 | 11/66/77 | RNASET2 |
Dominant | 1 | rs2677879 | 18 | 2537500 | 3.905 | 0.0481 | 5.79 | 0.0161 | 6.669 | 0.0098 | 0.0491* | 16.31 | 5.37E-05 | 13/51/84 | 28/73/51 | METTL4 |
Dominant | 2 | rs1047406 | 8 | 22626880 | 7.581 | 0.0059 | 4.356 | 0.0369 | 0.4674 | 0.4942 | 0.4942 | 10.69 | 0.001078 | 10/52/87 | 13/80/61 | PEBP4 |
Dominant | 3 | rs11205415 | 1 | 247087307 | 4.237 | 0.0396 | 4.381 | 0.0363 | 1.34 | 0.2471 | 0.4118 | 10.17 | 0.00143 | 23/68/58 | 28/92/34 | LOC727776 |
Dominant | 4 | rs2240308 | 17 | 60985053 | 4.246 | 0.0393 | 5.061 | 0.0245 | 0.7561 | 0.3845 | 0.4806 | 8.659 | 0.003254 | 16/74/59 | 16/51/87 | AXIN2 |
Dominant | 5 | rs3777722 | 6 | 167272094 | 4.439 | 0.0351 | 6.171 | 0.013 | 3.221 | 0.0727 | 0.1818 | 2.725 | 0.09881 | 20/68/60 | 11/66/77 | RNASET2 |
Recessive | 1 | rs3803800 | 17 | 7403693 | 5.97 | 0.0146 | 6.008 | 0.0142 | 0.0048 | 0.9445 | 0.9445 | 8.762 | 0.003076 | 20/73/56 | 6/75/73 | TNFSF13 |
Recessive | 2 | rs3213706 | 11 | 22837578 | 4.37 | 0.0366 | 7.551 | 0.006 | 0.1556 | 0.6932 | 0.9445 | 5.98 | 0.01447 | 8/73/68 | 21/58/75 | LOC645581 |